Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)

NCT02732678 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Angiosarcoma

Interventions

DRUG: PROPRANOLOL

Sponsor

Assistance Publique Hopitaux De Marseille